ClinicalTrials.Veeva

Find clinical trials for Endometrial Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Salt Lake City, UT, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Abemaciclib
Drug: Letrozole

Phase 2

Gynecologic Oncology Group (GOG)

Salt Lake City, Utah, United States and 28 other locations

compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...

Active, not recruiting
Advanced, Persistent, or Recurrent Endometrial Cancer
Drug: Medroxyprogesterone Acetate
Drug: Tamoxifen

Phase 2

GOG Foundation

Salt Lake City, Utah, United States and 25 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Salt Lake City, Utah, United States and 168 other locations

in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...

Enrolling
Endometrial Cancer
Hormone Receptor-positive Breast Cancer
Drug: PRO1184

Phase 1, Phase 2

ProfoundBio

West Valley City, Utah, United States of America and 15 other locations

Locations recently updated

This is a global, open-label, multicenter Phase 1/2 study to evaluate the safety, tolerability, PK, and antitumor activity of PRO1107 in patients wit...

Enrolling
Endometrial Cancer
Non-small Cell Lung Cancer
Drug: PRO1107

Phase 1, Phase 2

ProfoundBio

Salt Lake City, Utah, United States and 3 other locations

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling
Platinum-resistant Ovarian Cancer
Endometrial Cancer
Drug: NKT3447

Phase 1

NiKang Therapeutics

West Valley City, Utah, United States of America and 4 other locations

The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: TOS-358

Phase 1

Totus Medicines

West Valley City, Utah, United States and 11 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Salt Lake City, Utah, United States and 66 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Esophageal Cancer
Urologic Cancer
Drug: Niraparib

Phase 2

Tempus AI

Salt Lake City, Utah, United States and 79 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Salt Lake City, Utah, United States and 123 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems